In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Indacaterol Acetate Drug Master File in Korea (Indacaterol Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Indacaterol Acetate. The MFDS reviews the Indacaterol Acetate KDMF as part of the drug registration process and uses the information provided in the Indacaterol Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Indacaterol Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Indacaterol Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Indacaterol Acetate suppliers with KDMF on PharmaCompass.